With a market cap of $17.3 billion, C.H. Robinson Worldwide, Inc. (CHRW) is a global leader in Lean AI supply chains, helping 75,000 customers and 450,000 contract carriers move goods faster, smarter, and more sustainably. With more than a century of experience and 37 million shipments managed annually across truckload, LTL, ocean, air, and more, the company combines human expertise with Lean AI to build tomorrow’s supply chains today.
Shares of the Eden Prairie, Minnesota-based company have outperformed the broader market over the past 52 weeks. CHRW stock has jumped nearly 27% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 21.3%. However, shares of the company are down 7.8% on a YTD basis, lagging behind SPX’s 13.3% gain.
Focusing more closely, shares of the freight forwarding firm have outpaced the State Street Industrial Select Sector SPDR ETF’s (XLI) 22.4% return over the past 52 weeks.
C.H. Robinson has outperformed over the past year mainly due to AI-driven margin improvements, stronger execution, and improved North American Surface Transportation performance.
Nevertheless, the stock tumbled 15.4% following its Q2 2026 results on Jul. 29, amid concerns over the ongoing legal appeal process. The selloff was also driven by tightening freight capacity and cost pressures, including a 29% year-over-year increase in truckload linehaul costs that pressured contractual margins, higher insurance costs, and expectations for a 34% full-year increase in dry-van spot rates, up sharply from the previous 17% forecast. Although Q2 revenue rose 19.3% and AGP increased 6.5%, C.H. Robinson cut 2026 capex guidance to $65 million - $75 million, adding to concerns.
For the fiscal year ending in December 2026, analysts expect C.H. Robinson’s adjusted EPS to grow 21.4% year-over-year to $6.18. The company's earnings surprise history is promising. It topped the consensus estimates in each of the last four quarters.
Among the 25 analysts covering the stock, the consensus rating is a “Moderate Buy.” That’s based on 17 “Strong Buy” ratings, one “Moderate Buy,” six “Holds,” and one “Strong Sell.”
This configuration is more bullish than three months ago, with 15 “Strong Buy” ratings on the stock.
On Jul. 30, JPMorgan analyst Brian Ossenbeck raised C.H. Robinson’s price target to $225 while maintaining an “Overweight” rating.
The mean price target of $203.28 represents a 37.1% premium to CHRW’s current price levels. The Street-high price target of $237 suggests a 59.8% potential upside.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.